Summary
Peter Diamandis interviews Ben Lamm, CEO of Colossal Biosciences, on building a synthetic biology platform powered by AI. Colossal ($10B valuation in 4 years) is engineering de-extinction (woolly mammoth, Tasmanian tiger, direwolves), spinning out companies like Breaking (plastic degradation via enzyme-producing microbes), and developing artificial wombs for productionized species development.
Key Segments
- [00:02] Origin story: George Church's woolly mammoth dream becomes Colossal; zero to $10B in 4 years
- [00:04] Platform thesis: de-extinction as the hardest biology problem forces solving genotype-to-phenotype, comparative genomics
- [00:05] Breaking spinout: microbes that break chemical bonds of plastic (not just making smaller microplastics)
- [00:08] Direwolves created from 73,000-year-old skull in 18 months; George R.R. Martin's reaction
- [00:10] Country-as-customer model: UAE's nine-figure Biovault initiative for biodiversity preservation
- [00:14] Artificial womb program: three moonshots across different animal clades for productionized species development
- [00:17] AI-powered phenotype design: engineering tusk length, disease resistance, drought-resistant plants
- [00:23] Gene drives for invasive species: $5.4T global problem; screworm declared Texas national emergency
Notable Claims
- Colossal has 260 scientists (200 US, 60 Australia)
- Viagen (acquired) achieves 78% cloning efficiency vs industry standard 2%
- Global consumers spend $1.7T annually on extinct-species-related products (EY estimate)
- Invasive species problem valued at $5.4T globally
- Lamm: synthetic biology paired with AI will be the most transformative technology humanity ever has
Guests
- Ben Lamm — CEO, Colossal Biosciences
RDCO Mapping
- AI + biology convergence: Colossal's platform exemplifies AI as enabling layer for non-software industries
- Platform thinking: de-extinction as wedge problem to build generalizable synthetic biology engine
- Country-as-customer: government deals as business model for deep-tech companies
Related
- [[synthetic-biology]]
- [[ai-applications]]
- [[abundance-thinking]]
- [[exponential-technologies]]